A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE

Name: A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
Published: 2022
License: Public Domain

Anthos Therapeutics, Inc. · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

cat pulmonary-embolism venous-thromboembolism

venous thromboembolism, deep venous thrombosis, pulmonary embolism, anticoagulants, vte recurrence rate, probe design, lmwh, cat, cancer associated vte, abelacimab, apixaban, fxi

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 1009685
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.